BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
 
Neutral Fielding - a New Industry First Improves the Accuracy of Genius Image Analysers

12th December 2003 Cambridge, UK: Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce the availability of Neutral Fielding on all Genius image analysis systems. This new feature, exclusive to Syngene, can be used to automatically eliminate uneven light illumination and lens distortion effects to generate more precise images of fluorescent and visible dye labelled gels.

Based on a set of powerful algorithms, Neutral Fielding can correct for uneven illumination effects without altering the signal on the gel. This results in an image with a flat, even background, ensuring the benefit of accurate quantification of true spots and bands. GLP compliance is guaranteed during image capture and application of Neutral Fielding, since the Genius’ camera settings provide feedback to the software about each image. For each gel image the software recognises whether a previously acquired Neutral Field can be used or a new one has to be captured, making it impossible to apply an inappropriate Neutral Field.

Neutral Fielding now comes as standard on all models in the Genius range. This includes Syngene’s high performance, 16 bit technology systems, the GeneGenius gel image analyser and ChemiGenius2 the ultimate multi-functional analyser for chemiluminescent, fluorescent and visible dye labelled applications.

Paul Ellwood, Syngene’s Sales and Marketing Director stated: “Neutral Fielding is another great new innovation from Syngene. There is nothing currently on the market to rival this feature and it puts the Genius range out there in a class of its own. For scientists that demand the most accurate quantification, Neutral Fielding will make a Genius, the system of choice.”

-Ends-


For Further Information Contact:

Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.

Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101

Email: jayne.arthur@syngene.com  Web site: www.syngene.com 

 

Editor Contact:

Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.

Tel/Fax +44 (0) 1462- 635327 Email: sue6.pearson@ntlworld.com

Note to Editors

Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997, is a division of the Synoptics Group based in Cambridge, UK. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 55 people in its UK and subsidiary operation in Frederick, USA. The Group has profitable revenue of almost $10 million and continues to grow rapidly.

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.